AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer - a retrospective multi-centre study.

scientific article published on 19 April 2018

AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer - a retrospective multi-centre study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1103463128
P356DOI10.1186/S12885-018-4289-6
P932PMC publication ID5909228
P698PubMed publication ID29673336

P50authorVeronika SeebacherQ88410766
P2093author name stringNicole Concin
Stephan Polterauer
Alexander Reinthaller
Heinz Koelbl
Astrid Berger
Regina Achleitner
P2860cites workABO blood group and incidence of epithelial ovarian cancerQ24599521
Global cancer statistics, 2012Q27860501
Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancerQ33783766
The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy.Q53574858
Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.Q54448028
Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancerQ60685706
Analysis of antigen expression at multiple tumor sites in epithelial ovarian cancerQ67680941
Expression of A, B, and H blood group antigens in epithelial ovarian cancer: relationship to tumor grade and patient survivalQ71215855
Blood groups of the ABO system and survival rate in gynecologic tumorsQ71945863
Histo-blood group A/B antigen deletion/reduction vs. continuous expression in human tumor cells as correlated with their malignancyQ74428806
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe OvarialQ83287534
ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinomaQ84947425
FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic OncologyQ33922334
ABH and Lewis histo-blood group antigens in cancerQ34215529
Red blood cell blood group antigens: structure and functionQ34311979
AB0 blood group and prognosis in patients with pancreatic cancerQ34354138
ABO blood groups and risk of cancer: a systematic review and meta-analysisQ34662761
The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian TumorsQ35663610
Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor statusQ35822048
Prognostic Impact of ABO Blood Group on the Survival in Patients with Ovarian CancerQ35978580
The Rh protein family: gene evolution, membrane biology, and disease associationQ37642606
A brief history of human blood groupsQ41208027
Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.Q41345298
Human epithelial ovarian cancer allelotype.Q53480313
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectovarian cancerQ172341
P304page(s)447
P577publication date2018-04-19
P1433published inBMC CancerQ326300
P1476titleAB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer - a retrospective multi-centre study
P478volume18

Reverse relations

Q64986685AB0 Blood Group and Ovarian Cancer Survival.cites workP2860

Search more.